2026 NPPES data Research Study Specialist NPI 1700204005 M.D.
Verify on CMS →

ANTONIO PORTILLA-CINTRON, M.D.

Research Study Specialist in DAYTONA BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
8K
Medicare Part D claims · 601 beneficiaries · Research Study Specialist avg: 601
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$119.53
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ANTONIO PORTILLA-CINTRON, M.D. is a Research Study Specialist ([object Object]) practicing in DAYTONA BEACH, Florida with a Medicare Part D prescribing footprint of 8K claims across 601 beneficiaries — 16% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $119.53 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ANTONIO PORTILLA-CINTRON, M.D. reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 7,577 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ANTONIO PORTILLA-CINTRON, M.D. at a glance

Below national average

NPI registry status

Active

Issued 04/03/2014

NPI 1700204005

Primary specialty

Research Study Specialist

Rare

472 US NPIs in this specialty

Medicare Part D claims

7,577 1161% vs specialty avg

2023 prescription claims

Specialty avg: 601

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Research Study Specialist compares to other specialties among Florida providers

Florida providers

Research Study Specialist share within Florida

1. Research Study Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Research Study Specialist share within Florida

Medicare quality performance — MIPS

ANTONIO PORTILLA-CINTRON, M.D.'s 2023 MIPS final score plotted against the Research Study Specialist national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Research Study Specialist) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Research Study Specialist) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANTONIO PORTILLA-CINTRON, M.D. is a Research Study Specialist provider practicing in DAYTONA BEACH, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1700204005. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ANTONIO PORTILLA-CINTRON, M.D. appears in the CMS NPPES registry as a Research Study Specialist provider holding M.D. credentials at 1630 MASON AVE STE C, DAYTONA BEACH, FL, 32117, with a listed phone of (386) 238-9064. NPI 1700204005 was issued on 04/03/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PORTILLA-CINTRON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 7,577 prescription claims written by this provider, covering 601 Medicare beneficiaries and totaling roughly $527K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 11.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Research Study Specialist is a narrow specialty nationwide, with 472 enrolled providers across 41 states and an average of 601 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1630 MASON AVE STE C
DAYTONA BEACH, FL 32117

Provider Details

NPI 1700204005
Specialty Research Study Specialist
Credentials M.D.
Gender Male
NPI Issued 04/03/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Hospital and facility affiliations

Facilities where ANTONIO PORTILLA-CINTRON, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EXCELLENCE HEALTH LLC
DAYTONA BEACH, FL
VOLUSIA HOSPITALISTS PLC
DAYTONA BEACH, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANTONIO PORTILLA-CINTRON, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$120

Largest payer

ACADIA Pharmaceuticals Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to ANTONIO PORTILLA-CINTRON, M.D.. To verify ANTONIO PORTILLA-CINTRON, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ANTONIO PORTILLA-CINTRON, M.D. — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 7,577 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,577
Total Claims
$527K
Total Drug Cost
601
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,699
Total Day Supply
159,250
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$346K
Generic Drug Cost
$176K
Opioid Claims
887 (11.7% rate)
Antibiotic Claims
329

Patient Demographics

Average Patient Age
76.7 years
Avg HCC Risk Score
3.22
Gender Split
61% female / 39% male
Age Distribution
<65: 71, 65-74: 185, 75-84: 193, 85+: 152

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
372
Atorvastatin Calcium
336
Eliquis
Apixaban
306
Furosemide
260
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
242
Gabapentin
220
Levothyroxine Sodium
206
Amlodipine Besylate
168
Potassium Chloride
165
Pantoprazole Sodium
148

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Research Study Specialist Overview

How ANTONIO PORTILLA-CINTRON, M.D. fits within the Research Study Specialist landscape nationally.

472
Research Study Specialist Providers in US
41
States with Research Study Specialist
601
Avg Claims per Provider

ANTONIO PORTILLA-CINTRON, M.D.'s 7,577 claims are above the specialty average of 601.

Nearby Research Study Specialist Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as PORTILLA-CINTRON.

Compare Research Study Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANTONIO PORTILLA-CINTRON, M.D.'s specialty?
ANTONIO PORTILLA-CINTRON, M.D. specializes in Research Study Specialist and practices in DAYTONA BEACH, Florida. Credentials: M.D..
How much does ANTONIO PORTILLA-CINTRON, M.D. prescribe under Medicare Part D?
In 2023, ANTONIO PORTILLA-CINTRON, M.D. wrote 7,577 Medicare Part D claims totaling $527K in drug costs for 601 beneficiaries.
What is ANTONIO PORTILLA-CINTRON, M.D.'s Medicare quality score?
ANTONIO PORTILLA-CINTRON, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ANTONIO PORTILLA-CINTRON, M.D. located?
ANTONIO PORTILLA-CINTRON, M.D. is located at 1630 MASON AVE STE C, DAYTONA BEACH, FL, 32117. Phone: (386) 238-9064.
What is ANTONIO PORTILLA-CINTRON, M.D.'s NPI number?
ANTONIO PORTILLA-CINTRON, M.D.'s National Provider Identifier (NPI) is 1700204005, issued on 04/03/2014.
Does ANTONIO PORTILLA-CINTRON, M.D. prescribe more brand-name or generic drugs?
ANTONIO PORTILLA-CINTRON, M.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $346K in brand drug costs.
Does ANTONIO PORTILLA-CINTRON, M.D. prescribe opioids?
Yes, ANTONIO PORTILLA-CINTRON, M.D. had 887 opioid claims in 2023 with an opioid prescribing rate of 11.7%.
How many Research Study Specialist providers are there in the US?
There are 472 Research Study Specialist providers across 41 states in the US. The average Research Study Specialist provider writes 601 Medicare Part D claims per year.
What drugs does ANTONIO PORTILLA-CINTRON, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ANTONIO PORTILLA-CINTRON, M.D.'s most frequently prescribed drugs include Hydrocodone-Acetaminophen, Atorvastatin Calcium, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANTONIO PORTILLA-CINTRON, M.D. accept Medicare?
ANTONIO PORTILLA-CINTRON, M.D. appears in CMS Medicare data with 7,577 Part D claims and 601 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANTONIO PORTILLA-CINTRON, M.D.'s credentials?
ANTONIO PORTILLA-CINTRON, M.D.'s NPI is 1700204005 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology